Integra Lifesciences Holdings Corp (IART)

48.89
1.16 2.32
NASDAQ : Health Care
Prev Close 50.05
Open 50.06
Day Low/High 48.43 / 50.35
52 Wk Low/High 54.75 / 81.82
Volume 1.10M
Avg Volume 536.30K
Exchange NASDAQ
Shares Outstanding 78.08M
Market Cap 4.05B
EPS 1.00
P/E Ratio 63.27
Div & Yield N.A. (N.A)

Latest News

Integra's DuraSeal® Dural Sealant Saves Healthcare Costs According To A Study Recently Published In The Journal Of Health Economics And Outcomes Research

Integra's DuraSeal® Dural Sealant Saves Healthcare Costs According To A Study Recently Published In The Journal Of Health Economics And Outcomes Research

Hospitals can reduce costs of cerebrospinal fluid (CSF) leaks after posterior fossa surgeries by using DuraSeal® instead of fibrin glue

IART: Insiders vs. Shorts

The most recent short interest data was recently released for the 07/14/2017 settlement date, and Integra LifeSciences Holdings Corp is one of the most shorted stocks of the Russell 3000, based on 9.31 "days to cover" versus the median component at 6.16. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Johnson & Johnson Signals It Could Make Additional Divestitures

Johnson & Johnson Signals It Could Make Additional Divestitures

CFO Dominic Caruso said on an earnings call that ongoing reviews of the company's portfolio "suggest we currently have more opportunity to divest some nonstrategic businesses."

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra announced in February its intent to acquire Codman Neurosurgery from Johnson & Johnson.

Integra LifeSciences Launches SurgiMend® MP Collagen Matrix For Hernia Repair

SurgiMend MP is a collagen matrix for soft tissue reconstruction, featuring a highly macroporous design

Integra LifeSciences Announces Expansion Of Credit Facility To Include New $700 Million Term Loan

Financing now secured for the planned acquisition of Codman Neurosurgery

Dr. Reddy's And Integra LifeSciences Enter Into An Agreement To Market And Distribute DuraGen Plus® And Suturable DuraGen® Dural Regeneration In India

Dr. Reddy's Laboratories Limited (BSE:500124, NSE:DRREDDY, NYSE:RDY) and Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that they have entered into an...

Integra LifeSciences Reports Fourth Quarter And Full-Year 2016 Financial Results And Updates 2017 Full-Year Guidance

2016 Results and 2017 Guidance in line with January 10, 2017 Preliminary Announcement

Integra Scoops up JNJ's Codman Neurosurgery for $1.05 Billion

Integra Scoops up JNJ's Codman Neurosurgery for $1.05 Billion

Integra hopes this deal will grow its revenue to $2 billion sooner than expected.

Integra Scoops Up JNJ's Codman Neurosurgery for $1.05 Billion

Integra Scoops Up JNJ's Codman Neurosurgery for $1.05 Billion

The company hopes the JNJ assets will give revenue growth a boost.

Derma Sciences Soars Almost 40% on Buyout by Integra

Derma Sciences Soars Almost 40% on Buyout by Integra

The company's shares hit $6.95 Wednesday midday.

TheStreet Quant Rating: B (Buy)